Interferon beta in relapsing-remitting multiple sclerosis: an independent postmarketing study in southern Italy
María Trojano(University of Bari Aldo Moro), Carlo Avolio(University of Foggia), Aurora Fuiani(Ospedali Riuniti di Foggia), Maria Liguori(University of Bari Aldo Moro), Damiano Paolicelli(University of Bari Aldo Moro), Paolo Livrea(University of Bari Aldo Moro), Fabrizio Giuliani(University of Alberta), Giovanni Bosco Zimatore, Francesca De Robertis(University of Bari Aldo Moro)
Cited by 67
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
|Nature Medicine|2007|1.8k
Multiple Sclerosis Severity Score
|Neurology|2005|959
The Role of Inflammation in Depression and Fatigue
|Frontiers in Immunology|2019|651
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624